Effect of moxibustion for Hwa-byung
- Conditions
- Mental and behavioral disorders
- Registration Number
- KCT0002141
- Lead Sponsor
- Korea Institute of Oriental Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 20
(1) Males and females aged 20 to 65
(2) Diagnosed as Hwabyung based on a structure interview (SCID) for Hwabyung
(3) Willingness to provide written informed consent.
(1) Seriously unstable medical condition
(2) History or presence of severe mental diseases such as bipolar disorder or schizophrenia
(3) Thyroid stimulating hormone level 1.5 times lower than the normal lower limit
(4) Hemoglobin A1c =8 %
(5) Medical treatment related to Hwa-byung within the last 2 weeks
(6) Known hypersensitivity reactions or severe adverse events after moxibustion treatment, or an inability to receive moxibustion treatment by some reasons, especially difficulty in breathing
(7) Pregnancy, breast-feeding, or women without proper contraception
(8) Participants in other clinical trials
(9) Residents of collective dwelling facilities such as social welfare institutions
(10) Unwillingness to provide written informed consent
(11) Participants judged unsuitable for the clinical trial by the investigator.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hwa-byung symptom scale
- Secondary Outcome Measures
Name Time Method Korean-Beck Depression Inventory-II (K-BDI-II);Symptom CheckList-90-Revised (SCL-90-R);Instrument of pattern identification for Hwa-byung ;Recruitment rate, completion rate, and adherence